Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1994 Oct;98(1):21–28. doi: 10.1111/j.1365-2249.1994.tb06601.x

In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis.

A Lauhio 1, T Salo 1, Y Ding 1, Y T Konttinen 1, D Nordström 1, H Tschesche 1, J Lähdevirta 1, L M Golub 1, T Sorsa 1
PMCID: PMC1534162  PMID: 7923879

Abstract

We studied the in vivo effect of long-term doxycycline treatment combined with NSAID on human interstitial collagenases, other matrix metalloproteinases, serine proteinases, tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) and lactoferrin from saliva and serum during the course of acute reactive arthritis (ReA). Collagenase activity and serine proteases (elastase-like, cathepsin G-like and trypsin-like activities) of saliva (n = 10) and gelatinase, lactoferrin and TIMP-1 of saliva (n = 10) and serum (n = 10) samples before and after 2 months doxycycline treatment, combined with NSAID, were studied by quantitative SDS-PAGE assay, ELISA assay and by spectrophotometric assay. The cellular source and molecular forms of salivary collagenase were characterized by immunoblotting using specific antisera. We found that activities of total and endogenously active interstitial collagenase reduced significantly. The salivary collagenase was found to originate from neutrophils. No fragmentation of either pro 75-kD and active 65-kD MMP-8 was detected after 2 months doxycycline treatment. However, during 2 months doxycycline and NSAID treatment no reduction of salivary and serum gelatinase, lactoferrin and TIMP-1-levels and salivary serine protease activities were detected. The in vivo inhibition of collagenase (MMP-8) activity during long-term doxycycline therapy in human saliva containing inflammatory exudate of ReA patients may contribute to the reduced tissue destruction observed in recent clinical and animal model studies in arthritides during long-term doxycycline/tetracycline treatment.

Full text

PDF
21

Images in this article

25Fig. 2
on p.25
26Fig. 3
on p.26

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ainamo J., Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975 Dec;25(4):229–235. [PubMed] [Google Scholar]
  2. Bardin T., Enel C., Cornelis F., Salski C., Jorgensen C., Ward R., Lathrop G. M. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum. 1992 Feb;35(2):190–194. doi: 10.1002/art.1780350210. [DOI] [PubMed] [Google Scholar]
  3. Bergmann U., Michaelis J., Oberhoff R., Knäuper V., Beckmann R., Tschesche H. Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase. J Clin Chem Clin Biochem. 1989 Jun;27(6):351–359. doi: 10.1515/cclm.1989.27.6.351. [DOI] [PubMed] [Google Scholar]
  4. Breedveld F. C., Dijkmans B. A., Mattie H. Minocycline treatment for rheumatoid arthritis: an open dose finding study. J Rheumatol. 1990 Jan;17(1):43–46. [PubMed] [Google Scholar]
  5. Gabler W. L., Smith J., Tsukuda N. Comparison of doxycycline and a chemically modified tetracycline inhibition of leukocyte functions. Res Commun Chem Pathol Pharmacol. 1992 Nov;78(2):151–160. [PubMed] [Google Scholar]
  6. Golub L. M., Ciancio S., Ramamamurthy N. S., Leung M., McNamara T. F. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res. 1990 Nov;25(6):321–330. doi: 10.1111/j.1600-0765.1990.tb00923.x. [DOI] [PubMed] [Google Scholar]
  7. Golub L. M., Suomalainen K., Sorsa T. Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent. 1992 Mar;2:80–90. [PubMed] [Google Scholar]
  8. Granfors K. Do bacterial antigens cause reactive arthritis? Rheum Dis Clin North Am. 1992 Feb;18(1):37–48. [PubMed] [Google Scholar]
  9. Granfors K., Jalkanen S., Lindberg A. A., Mäki-Ikola O., von Essen R., Lahesmaa-Rantala R., Isomäki H., Saario R., Arnold W. J., Toivanen A. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet. 1990 Mar 24;335(8691):685–688. doi: 10.1016/0140-6736(90)90804-e. [DOI] [PubMed] [Google Scholar]
  10. Granfors K., Jalkanen S., von Essen R., Lahesmaa-Rantala R., Isomäki O., Pekkola-Heino K., Merilahti-Palo R., Saario R., Isomäki H., Toivanen A. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med. 1989 Jan 26;320(4):216–221. doi: 10.1056/NEJM198901263200404. [DOI] [PubMed] [Google Scholar]
  11. Greenwald R. A., Moak S. A., Ramamurthy N. S., Golub L. M. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol. 1992 Jun;19(6):927–938. [PubMed] [Google Scholar]
  12. Ingman T., Sorsa T., Konttinen Y. T., Liede K., Saari H., Lindy O., Suomalainen K. Salivary collagenase, elastase- and trypsin-like proteases as biochemical markers of periodontal tissue destruction in adult and localized juvenile periodontitis. Oral Microbiol Immunol. 1993 Oct;8(5):298–305. doi: 10.1111/j.1399-302x.1993.tb00578.x. [DOI] [PubMed] [Google Scholar]
  13. Ingman T., Sorsa T., Suomalainen K., Halinen S., Lindy O., Lauhio A., Saari H., Konttinen Y. T., Golub L. M. Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article. J Periodontol. 1993 Feb;64(2):82–88. doi: 10.1902/jop.1993.64.2.82. [DOI] [PubMed] [Google Scholar]
  14. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med. 1983 Dec 29;309(26):1606–1615. doi: 10.1056/NEJM198312293092604. [DOI] [PubMed] [Google Scholar]
  15. Keat A., Thomas B., Dixey J., Osborn M., Sonnex C., Taylor-Robinson D. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet. 1987 Jan 10;1(8524):72–74. doi: 10.1016/s0140-6736(87)91910-6. [DOI] [PubMed] [Google Scholar]
  16. Konttinen Y. T., Lindy O., Suomalainen K., Ritchlin C., Saari H., Vauhkonen M., Lauhio A., Santavirta S., Sorsa T. Substrate specificity and activation mechanisms of collagenase from human rheumatoid synovium. Matrix. 1991 Dec;11(6):395–403. doi: 10.1016/s0934-8832(11)80194-0. [DOI] [PubMed] [Google Scholar]
  17. Lauhio A., Leirisalo-Repo M., Lähdevirta J., Saikku P., Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum. 1991 Jan;34(1):6–14. doi: 10.1002/art.1780340103. [DOI] [PubMed] [Google Scholar]
  18. Lauhio A., Lähdevirta J., Janes R., Kontiainen S., Repo H. Reactive arthritis associated with Shigella sonnei infection. Arthritis Rheum. 1988 Sep;31(9):1190–1193. doi: 10.1002/art.1780310917. [DOI] [PubMed] [Google Scholar]
  19. Lauhio A. Reactive arthritis. Consider combination treatment. BMJ. 1994 May 14;308(6939):1302–1303. [PMC free article] [PubMed] [Google Scholar]
  20. Lauhio A., Sorsa T., Lindy O., Suomalainen K., Saari H., Golub L. M., Konttinen Y. T. The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis. Arthritis Rheum. 1992 Feb;35(2):195–198. doi: 10.1002/art.1780350211. [DOI] [PubMed] [Google Scholar]
  21. Lauhio A., Sorsa T., Lindy O., Suomalainen K., Saari H., Golub L. M., Konttinen Y. T. The regulatory role of doxycycline/tetracycline in collagenolytic activity and tissue destruction in joint diseases: comment on the article by Yu et al. Arthritis Rheum. 1993 Sep;36(9):1335–1336. doi: 10.1002/art.1780360924. [DOI] [PubMed] [Google Scholar]
  22. Michaelis J., Vissers M. C., Winterbourn C. C. Human neutrophil collagenase cleaves alpha 1-antitrypsin. Biochem J. 1990 Sep 15;270(3):809–814. doi: 10.1042/bj2700809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Osthues A., Knäuper V., Oberhoff R., Reinke H., Tschesche H. Isolation and characterization of tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) from human rheumatoid synovial fluid. FEBS Lett. 1992 Jan 13;296(1):16–20. doi: 10.1016/0014-5793(92)80393-u. [DOI] [PubMed] [Google Scholar]
  24. Rahman M. U., Hudson A. P., Schumacher H. R., Jr Chlamydia and Reiter's syndrome (reactive arthritis). Rheum Dis Clin North Am. 1992 Feb;18(1):67–79. [PubMed] [Google Scholar]
  25. Ramamurthy N. S., Vernillo A. T., Greenwald R. A., Lee H. M., Sorsa T., Golub L. M., Rifkin B. R. Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J Bone Miner Res. 1993 Oct;8(10):1247–1253. doi: 10.1002/jbmr.5650081013. [DOI] [PubMed] [Google Scholar]
  26. Sorsa T. A. Activation of latent collagenase purified from human leukocytes. Scand J Rheumatol. 1987;16(3):167–175. doi: 10.3109/03009748709165270. [DOI] [PubMed] [Google Scholar]
  27. Sorsa T., Lindy O., Konttinen Y. T., Suomalainen K., Ingman T., Saari H., Halinen S., Lee H. M., Golub L. M., Hall J. Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase. Antimicrob Agents Chemother. 1993 Mar;37(3):592–594. doi: 10.1128/aac.37.3.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sorsa T., Uitto V. J., Suomalainen K., Turto H., Lindy S. A trypsin-like protease from Bacteroides gingivalis: partial purification and characterization. J Periodontal Res. 1987 Sep;22(5):375–380. doi: 10.1111/j.1600-0765.1987.tb01602.x. [DOI] [PubMed] [Google Scholar]
  29. Suomalainen K., Sorsa T., Golub L. M., Ramamurthy N., Lee H. M., Uitto V. J., Saari H., Konttinen Y. T. Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrob Agents Chemother. 1992 Jan;36(1):227–229. doi: 10.1128/aac.36.1.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Toivanen A., Yli-Kerttula T., Luukkainen R., Merilahti-Palo R., Granfors K., Seppälä J. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol. 1993 May-Jun;11(3):301–307. [PubMed] [Google Scholar]
  31. Turto H., Lindy S., Uitto V. J., Wegelius O., Uitto J. Human leukocyte collagenase: characterization of enzyme kinetics by a new method. Anal Biochem. 1977 Dec;83(2):557–569. doi: 10.1016/0003-2697(77)90059-8. [DOI] [PubMed] [Google Scholar]
  32. Uitto V. J., Larjava H., Heino J., Sorsa T. A protease of Bacteroides gingivalis degrades cell surface and matrix glycoproteins of cultured gingival fibroblasts and induces secretion of collagenase and plasminogen activator. Infect Immun. 1989 Jan;57(1):213–218. doi: 10.1128/iai.57.1.213-218.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Uitto V. J., Suomalainen K., Sorsa T. Salivary collagenase. Origin, characteristics and relationship to periodontal health. J Periodontal Res. 1990 May;25(3):135–142. doi: 10.1111/j.1600-0765.1990.tb01035.x. [DOI] [PubMed] [Google Scholar]
  34. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]
  35. Yu L. P., Jr, Smith G. N., Jr, Brandt K. D., Myers S. L., O'Connor B. L., Brandt D. A. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum. 1992 Oct;35(10):1150–1159. doi: 10.1002/art.1780351007. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES